OVARIAN CANCER MANIFESTED BY MESENTERIC AND HEPATIC VENOUS THROMBOSIS

Download full text PDF
Issue: 
11
Year: 
2016

Yu. Magdebura (1); A. Solopova (2), Candidate of Medical Sciences 1 -S.P. Botkin City Clinical Hospital, Moscow 2 -I.M. Sechenov First Moscow State Medical University

The paper describes a case of nonspecific manifestation of ovarian cancer, which reflects the typical complexities of a clinical search and the possible variants of increasing the informative value of studies to make an accurate diagnosis.

Keywords: 
oncology
ovarian cancer
coagulopathy
thrombosis
magnetic resonance tomography
diffusion-weighted images



It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Zlokachestvennye novoobrazovanija v Rossii v 2014 godu (zabolevaemost' i smertnost'). Pod red. A.D. Kaprina, V.V. Starinskogo, G.V. Petrovoj / M.: MNIOI im. P.A. Gertsena, 2016.
  2. Prat J. Staging classification for cancer of the ovary, fallopian tube and peritoneum // Intern. J. Gynecol. Obstet. – 2014; 124 (1): 1–5.
  3. Siegel R., Ma J., Zou Z. et al. Cancer statistics, 2014 / CA: A Cancer Journal for Clinicians, 2014; 64.
  4. SEER Cancer Statistics Factsheets: Ovary Cancer. National Cancer Institute. Bethesda. Avaible online at http://seer.cancer.gov/statfacts/html/ovary.html
  5. American Cancer Society. Cancer Facts & Figures 2016 / Atlanta: American Cancer Society, 2016.
  6. Mohaghegh P., Rockall A. Imaging Strategy for Early Ovarian Cancer: Characterization of Adnexal Masses with Conventional and Advanced Imaging Techniques // Radiographics. – 2012; 32 (6): DOI 10.1148/326125520.
  7. Bahtiozin R.F., Safiullin R.R. Diffuzionno-vzveshennoe izobrazhenie vsego tela v diagnostike onkologicheskih zabolevanij // Kubanskij nauchnyj meditsinskij vestnik. – 2010; 6: 16–20.
  8. Falanga A. Mechanism of hypercoagulation in malignancy and during chemotherapy // Haemostasis. – 1998; 28 (3): 50–60.
  9. Vorob'ev A.V., Makatsarija A.D. Trombofilija, trombozy i antitromboticheskaja terapija u onkologicheskih bol'nyh // Akusherstvo, ginekologija i reproduktsija. – 2014; 2: 139–48.
  10. Zhao T., Hu W. CA125 and HE4: Measurement Tools for Ovarian Cancer // Gynecol. Obstet. Invest. – 2016; DOI 10.1159/000442288.
  11. Anton C., Carvalho F., Oliveira E. et al. A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses // Clinics. – 2012; 67: 437–41. DOI 10.6061/clinics/2012(05)06.
  12. Harris R., Javitt M., Glanc Ph. et al. Clinically Suspected Adnexal Mass / ACR Appropriateness Criteria®, 2012.
  13. Forstner R. et al. ESUR guidelines: ovarian cancer staging and follow-up // Eur. Radiol. – 2010; 20: 2773–3780.
  14. Kaijser J., Bourne T., Valentin L. et al. Improving strategies for diagnosing ovarian cancer: a summary of the International Ovarian Tumor Analysis (IOTA) studies // Ultrasound Obstet. Gynecol. – 2013; 41: 9–20.
  15. Spencer J. et al. ESUR guidelines for MR imaging of the sonographically indeterminate adnexal mass: an algorithmic approach // Eur. Radiology. – 2010; 20: 25–35. DOI 10.1007/s00330-009-1584-2.
  16. Adusumilli S., Hussain H., Caoili E. et al. MRI of sonographically indeterminate adnexal masses // AJR Am. J. Roentgenol. – 2006; 187: 732–40.
  17. Sohaib S., Mills T., Sahdev A. et al. The role of magnetic resonance imaging and ultrasound in patients with adnexal masses // Clin. Radiol. – 2005; 60: 340–8.
  18. Solopova A.E., Chaschin A.A., Solopova A.G. i dr. Sovremennye vzgljady na patogenez i vozmozhnosti diagnostiki epitelial'nogo raka jaichnikov // Akusherstvo, ginekologija i reproduktsija. – 2016; 10 (1): 75–83.